| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46dc96703f91884ca652f3b70453a1ce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08 |
| filingDate |
2014-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c024d72802a734e6be2f07d1031b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f2061d7cc8d0c004da48726288c5cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4cb2f80e05c946ef24fb255d33b212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0388e2ce9f46cf0dd5dff733100f70 |
| publicationDate |
2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3007720-A1 |
| titleOfInvention |
Compositions comprising gc- macrophage activating factor and uses thereof |
| abstract |
The present invention relates to stable pharmaceutical compositions comprising Gc macrophage activating factor (GcMAF). The present invention relates in particular to storage-stable pharmaceutical compositions comprising GcMAF and at least one pharmaceutically acceptable surfactant and/or a synthetic water-soluble polymer having surface activity and uses thereof for treating diseases associated with macrophage activation. |
| priorityDate |
2013-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |